LINDSEY STONE: Open Payments
NPI 1154163459 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 27 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $477 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $409 |
| Amgen Inc. | 3 | $149 |
| Lilly USA, LLC | 2 | $54 |
| Exact Sciences Corporation | 2 | $50 |
| Astellas Pharma US Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 2 | $32 |
| Renalytix AI, Inc. | 2 | $29 |
| Verona Pharma, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, REPATHA, ZEPBOUND, The Cologuard Plus Collection Kit, Veozah, TRELEGY ELLIPTA, UBRELVY.
Industry payments across NY — which companies pay providers there.
